ID   LNCaP C4-2BR
AC   CVCL_F0L8
SY   C4-2BR
RX   PubMed=33799432;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4784 ! LNCaP C4-2B
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
RX   PubMed=33799432; DOI=10.3390/cancers13061290; PMCID=PMC7998254;
RA   Lima, Thiago S.
RA   Iglesias-Gato, Diego
RA   Souza, Luciano de Oliveira
RA   Stenvang, Jan
RA   Lima, Diego S.
RA   Roder, Martin Andreas
RA   Brasso, Klaus
RA   Moreira, Jose M.A.
RT   "Molecular profiling of docetaxel-resistant prostate cancer cells
RT   identifies multiple mechanisms of therapeutic resistance.";
RL   Cancers (Basel) 13:1290.1-1290.19(2021).
//